Acumen Pharmaceuticals, Inc. (ABOS)
USD 1.79
(-8.67%)
USD 1.79
(-8.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | 1.43 Million | 1.69 Million |
| Cost of Revenue | 42.31 Million | 169 Thousand | 4000.00 | 7997.00 | 8576.00 |
| Gross Profit | -42.31 Million | -169 Thousand | -4000.00 | 1.42 Million | 1.68 Million |
| Operating Expenses | 61.13 Million | 45.23 Million | 19.58 Million | 9.34 Million | 9.5 Million |
| Selling, General and Administrative Expenses | 18.82 Million | 12.87 Million | 7.27 Million | 1.35 Million | 926 Thousand |
| Research and Development Expenses | 42.31 Million | 32.36 Million | 12.3 Million | 7.99 Million | 8.57 Million |
| Other Expenses | - | -11 Thousand | 51 Thousand | - | - |
| Cost and Expenses | 61.13 Million | 45.23 Million | 19.58 Million | 9.34 Million | 9.5 Million |
| Operating Income | -61.13 Million | -45.23 Million | 61.57 Million | -7.91 Million | -7.8 Million |
| Interest Expense | - | - | - | - | - |
| Income Tax Expense | - | -2.38 Million | 81.07 Million | -1000.00 | -45 Thousand |
| Earnings before Tax | -52.37 Million | -42.85 Million | -100.6 Million | -7.32 Million | -7.9 Million |
| Net Income | -52.37 Million | -40.47 Million | -181.67 Million | -7.32 Million | -7.86 Million |
| Earnings Per Share Basic | -1.08 | -1.00 | -4.49 | -0.18 | -0.20 |
| Earnings Per Share Diluted | -1.08 | -1.00 | -4.49 | -0.18 | -0.20 |
| Weighted Average Shares Outstanding | 48.49 Million | 40.6 Million | 40.47 Million | 40.15 Million | 40.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.6 Million | 40.6 Million | 40.47 Million | 40.15 Million | 40.15 Million |
| Gross Margin | - | - | - | 0.99 | 0.99 |
| EBIT Margin | - | - | - | -5.92 | -4.51 |
| Profit Margin | - | - | - | -5.10 | -4.63 |
| EBITDA | -51.6 Million | -42.68 Million | 61.57 Million | 587 Thousand | 119 Thousand |
| Earnings Before Tax Margin | - | - | - | -5.51 | -4.60 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 290 Thousand | - | - | - |
| Cost of Revenue | 45 Thousand | 44 Thousand | 39 Thousand | 184 Thousand | 40 Thousand | 53 Thousand |
| Gross Profit | -45 Thousand | -44 Thousand | 251 Thousand | -184 Thousand | -40 Thousand | -53 Thousand |
| Operating Expenses | 24.33 Million | 17.77 Million | 18.44 Million | 60.95 Million | 16.03 Million | 13.47 Million |
| Selling, General and Administrative Expenses | 4.8 Million | 5.32 Million | 5.15 Million | - | 4.86 Million | 4.34 Million |
| Research and Development Expenses | 19.53 Million | 12.44 Million | 13.29 Million | - | 11.17 Million | 9.13 Million |
| Other Expenses | -68 Thousand | -54 Thousand | -21 Thousand | - | -42 Thousand | -16 Thousand |
| Cost and Expenses | 24.38 Million | 17.77 Million | 18.48 Million | 61.13 Million | 16.03 Million | 13.47 Million |
| Operating Income | -24.38 Million | -17.77 Million | -18.48 Million | -61.13 Million | -16.03 Million | -13.47 Million |
| Interest Expense | 1 Million | -1 Million | 581 Thousand | -581 Thousand | - | - |
| Income Tax Expense | - | -44 Thousand | 3.75 Million | - | -40 Thousand | -1.88 Million |
| Earnings before Tax | -20.53 Million | -14.87 Million | -16.49 Million | -52.37 Million | -12.95 Million | -11.61 Million |
| Net Income | -20.53 Million | -14.87 Million | -16.49 Million | -52.37 Million | -12.95 Million | -11.61 Million |
| Earnings Per Share Basic | -0.34 | -0.25 | -0.28 | - | -0.24 | -0.28 |
| Earnings Per Share Diluted | -0.34 | -0.25 | -0.28 | - | -0.24 | -0.28 |
| Weighted Average Shares Outstanding | 60.07 Million | 59.81 Million | 57.91 Million | 48.6 Million | 54.22 Million | 41.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.07 Million | 59.81 Million | 57.91 Million | 48.6 Million | 54.22 Million | 41.02 Million |
| Gross Margin | - | - | 0.87 | - | - | - |
| EBIT Margin | - | - | -63.61 | - | - | - |
| Profit Margin | - | - | -56.89 | - | - | - |
| EBITDA | -24.33 Million | -17.77 Million | -18.44 Million | - | -16.03 Million | -13.42 Million |
| Earnings Before Tax Margin | - | - | -63.74 | - | - | - |
SKS
CWY
BYD
CCZ
WEGYF
EGDD